Effect of Metformin Therapy on Clinical and Hormonal Indices of Patients with Polycystic Ovary Syndrome

    May 2021
    Sara Inayat, H. F. Khattak, Maryam Muhammad … Fatima Fatima
    Studysummary This study found that metformin significantly improved clinical and hormonal indices in patients with polycystic ovary syndrome compared to pioglitazone, which also effectively controlled some symptoms.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on pjmhsonline.com →
    Discuss this study in the Community →

    Related research 2

    1. Metformin Therapy for the Reproductive and Metabolic Consequences of Polycystic Ovary Syndrome Diabetologia · 2017
    2. Metformin: An Old Medication of New Fashion: Evolving New Molecular Mechanisms and Clinical Implications in Polycystic Ovary Syndrome European journal of endocrinology · 2009